Privacy Policy
Signals Blog

Contributors

Categories

Cardiovascular regeneration at TMM 2021

The 2021 Till & McCulloch Meetings (TMM) are where the heart is. More specifically, I am referring to the major advances in cardiovascular regenerative medicine presented during the Bioengineering Regeneration plenary session on the final day of the conference. It...

World AIDS Day: exploring HIV cure research and gene therapies

To mark World AIDS Day, I caught up with the International AIDS Society (IAS) 2021 HIV Cure and Gene Therapy Forum’s opening session, which focused on the intersection between HIV cure research and rapidly advancing gene-based therapies. The session sought to address...

Engineering a future-proof stem cell policy

In a field as fast-paced as regenerative medicine, it’s vital that policy isn’t always playing catch-up. I caught up with Amy Zarzeczny’s presentation at the 2021 Till & McCulloch Meetings to find out how policy can stay ahead — or at least keep...

Till & McCulloch Meetings 2021: Cancer stem cells

While I have attended several Till & McCulloch Meetings in the past as a trainee and presenter, I have now had the privilege of attending as a cancer stem cell enthusiast and blogger – and I’m excited to share my perspective on some of the amazing talks! If you...

Right Turn: Commercializing Living Therapies podcast

In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM. Commercializing...

What does Jane Krakowski have to do with stem cells?

On October 5th, 2021, the New York Stem Cell Foundation (NYSCF) hosted its Annual Gala and Science Fair, Show Up for Science. Founded in 2005, NYSCF has been focusing on accelerating the development of new therapies and technologies for treating major diseases. This...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!